Last update 01 Nov 2024

sTn x Tubulin

Basic Info

Related Targets
sTnTubulin

Related

2
Drugs associated with sTn x Tubulin
ST1
Target
Tubulin x sTn
Mechanism
Tubulin inhibitors [+1]
Active Org.
Siamab Therapeutics, Inc.Siamab Therapeutics, Inc.
Originator Org.
Siamab Therapeutics, Inc.Siamab Therapeutics, Inc.
Active Indication
Ovarian Cancer
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
SGN-STNV
Target
Tubulin x sTn
Mechanism
Tubulin inhibitors [+1]
Active Org.-
Originator Org.
Seagen Inc.Seagen Inc.
Active Indication-
Inactive Indication
Advanced Malignant Solid Neoplasm [+11]
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with sTn x Tubulin
NCT04665921 / TerminatedPhase 1
A Phase 1 Study of SGN-STNV in Advanced Solid Tumors
100 Clinical Results associated with sTn x Tubulin
Login to view more data
100 Translational Medicine associated with sTn x Tubulin
Login to view more data
0 Patents (Medical) associated with sTn x Tubulin
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free